Delivery Order SPE2DB20D2014-SPE2DB25FC53A
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/mL 3mL insulin pens, with a ceiling value of $1,582.33 and a firm fixed price structure. The contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Tresiba FlexTouch 100 Unit/ML 3ML insulin pens, with a ceiling value of $1,384.20. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 24, 2025, and performance based in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's critical role as a pharmaceutical supplier to the federal government,...
- The Defense Logistics Agency awarded a $4,222.74 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 unit/ml insulin pens (3ml). This contract, awarded on July 21, 2025, represents a firm fixed-price procurement with an ultimate completion date of July 22, 2025. The award was not set-aside and was competitively awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at...
- The Defense Logistics Agency awarded a $4,152.30 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/ML 3ML insulin pens on July 21, 2025, with completion scheduled for July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $4,982.76 delivery order to AmerisourceBergen Drug Corp for TRESIBA FLEXTOUCH 200 Unit/ML 3ML insulin pens, with an ultimate completion date of July 23, 2025. This non-set-aside contract utilizes a firm fixed-price arrangement and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Tresiba FlexTouch 100 Unit/mL 3mL insulin pens. The $2,678.94 order will be delivered by January 18, 2024 to support DLA Troop Support Medical's provision of pharmaceuticals and supplies to military treatment facilities. Amerisourcebergen has a history of providing a range of pharmaceutical and medical products to DLA...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract for $2,001.55 to supply Tresiba Flextouch 200 unit/mL 3mL insulin pens. This delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
- The Defense Logistics Agency awarded a $2,338.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Tresiba FlexTouch insulin pens. The order is for 200 units per milliliter of the insulin in 3 milliliter pens. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania from September 18-19, 2023. The Defense Logistics Agency manages the Department of Defense's supply chain and procurement programs. This delivery order was issued under an...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of Tresiba Flextouch 100 unit/ml 3ml insulin pens, with a potential value of $2,001.06 and a completion date of February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $3,316.45 to Amerisourcebergen Drug Corporation for Tresiba FlexTouch insulin pens. Performance will take place in Conshohocken, Pennsylvania over a one day period from July 19th through July 20th, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will supply the requested insulin products to the Defense Logistics Agency under this order issued against their Prime Vendor Next...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC53ADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,768.40 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/mL 3mL insulin pens. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of July 23, 2025. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The SPE2DX prime indefinite delivery vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. Through this global pharmaceutical support contract, the company serves multiple federal healthcare customers including the Defense Health Agency and U.S. Coast Guard. This delivery order exemplifies the company's role as a key supplier within DLA's medical supply chain infrastructure for military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/22/25 |